麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors’ Liability Premiums
  • Florida鈥檚 KidCare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors' Liability Premiums
  • Florida鈥檚 KidCare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Mar 22 2024

Full Issue

Viewpoints: Cost Of TB Test Out Of Reach For Many; Some ACA Workers Cannot Afford Their Own Health Care

Editorial workers tackle tuberculosis testing, ACA, medical devices, and more.

Of the 10 million people who will become sick with tuberculosis this year, between 3 million and 4 million will go undiagnosed, often dying before they can get an accurate test. Fortunately, GeneXpert tests, made by the company Cepheid (a subsidiary of the conglomerate Danaher), can reliably determine within two hours if a patient has TB. (John Green, 3/21)

March 23 marks 14 years since the Affordable Care Act (ACA) was signed into law by former President Barack Obama. The ACA, as then-Vice President Joe Biden predicted, has been a lifeline for millions of Americans needing affordable health coverage. (Katherine Charles and Audrianna Lewis, 3/21)

This year 21.3 million Americans chose Affordable Care Act (ACA) marketplace coverage during the open enrollment period. About a fourth of those were new to the marketplace and 16 million Americans renewed their coverage. Despite its popularity and the fact that it's a lifeline for millions of people, former President Donald Trump is threatening to terminate it. (Jorge Neri, 3/22)

In a recent survey of U.S. companies, medical device makers reported spending $31 million on average to bring a new product to market under the Food and Drug Administration鈥檚 510(k) pathway for those similar to devices already approved. These costs balloon to more than $90 million for new Class III devices that progress through the more rigorous premarket approval pathway. (Kyle H. Sheetz and Robert M. Wachter, 3/22)

The adverse childhood experience (ACE) questionnaire has become a critical part of public health. It offers physicians a screening tool to evaluate patients, gaining valuable insights into their physical and mental well-being. However, the questionnaire is now outdated because it fails to ask about childhood exposure to gun violence. (Sydney Durrah, 3/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优